Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 22, 2022 01:30 ET | Source: Bavarian Nordic A/S

Bavarian Nordic har modtaget positiv anbefaling fra det Europæiske Lægemiddelagentur om udvidelse af godkendelsen af IMVANEX® til også at omfatte abekopper

KØBENHAVN, Danmark, 22. juli 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Udvalget for Humanmedicinske Lægemidler (CHMP) under Det Europæiske Lægemiddelagentur (EMA) har vedtaget en...
July 22, 2022 01:30 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Receives Positive CHMP Opinion on the Extension of Vaccine Label to Include Monkeypox

COPENHAGEN, Denmark, July 22, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...
July 19, 2022 02:30 ET | Source: Bavarian Nordic A/S

Bavarian Nordic indgår en betydelig kontrakt med europæisk land på koppe-/abekoppevaccine til levering i 2023

Bavarian Nordic skal levere 1,5 millioner doser IMVANEX®-vaccine til et ikke-oplyst europæisk landLeverancerne starter i fjerde kvartal 2022, men hovedparten af doserne skal leveres i 2023 ...
July 19, 2022 02:30 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Secures Significant European Smallpox/Monkeypox Vaccine Order for 2023

Bavarian Nordic to supply an additional 1.5 million doses of IMVANEX® vaccine to an undisclosed European countryDeliveries starting in the fourth quarter of 2022, but with the vast majority of doses...
July 18, 2022 05:37 ET | Source: Bavarian Nordic A/S

Bavarian Nordic indgår flere vaccinekontrakter med regeringer i forbindelse med globalt udbrud af abekopper

Flere kontrakter af varierende størrelser er indgåetLeverancerne vil starte øjeblikkeligt med henblik på at sikre et hurtigt beredskab mod det igangværende udbrud af abekopperSelskabet opjusterer sine...
July 18, 2022 05:37 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Enters Multiple Vaccine Contracts with Governments in Response to Global Monkeypox Outbreak

A number of contracts of varying size have been signedDeliveries to start immediately aiming to ensure a rapid response to the current monkeypox outbreakCompany upgrades its financial guidance for...
July 15, 2022 12:56 ET | Source: Bavarian Nordic A/S

Den amerikanske regering bestiller yderligere 2,5 mio. vacciner mod abekopper fra Bavarian Nordic

Bavarian Nordic skal levere yderligere 2,5 mio. doser JYNNEOS® vaccine, hvormed selskabet i alt vil levere næsten 7 mio. doser i 2022 og 2023Fyldekapaciteten udvides med en amerikansk...
July 15, 2022 12:56 ET | Source: Bavarian Nordic A/S

U.S. Government Orders Another 2.5 Million Doses of Monkeypox Vaccines from Bavarian Nordic

Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccine, bringing deliveries in 2022 and 2023 to a total of nearly 7 million dosesFilling capacity is being expanded with a U.S....
July 01, 2022 10:00 ET | Source: Bavarian Nordic A/S

Den amerikanske regering bestiller yderligere vacciner mod abekopper fra Bavarian Nordic

Bavarian Nordic skal levere yderligere 2,5 mio. doser JYNNEOS® vaccineRåvaccine, produceret under tidligere kontrakter med BARDA, vil blive anvendt til færdigproduktion af doserneLeverancerne vil...
July 01, 2022 10:00 ET | Source: Bavarian Nordic A/S

U.S. Government Orders Additional Monkeypox Vaccines from Bavarian Nordic

Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccineDoses will be manufactured using existing bulk vaccine from previous orders from BARDADeliveries starting in the fourth...